Espace MicroCaps is glad to invite you to its summer 2018 cocktail event, at the Bier Markt Montreal on Tuesday, June 19th at 5:00pm. Our events are the perfect occasion to improve your investing skills, discover new investment opportunities in the Canadian microcap space and network with likeminded investors.
The event will showcase three extremely promising companies from diverse industries: FLYHT Aerospace Solutions (TSX Venture: FLY), Ortho Regenerative Technologies (CSE: ORTH) and NuRAN Wireless (CSE: NUR).
Where: Bier Markt Montreal, 1221 René-Lévesque W, Montreal
When: Tuesday, June 19th from 5:00pm to 7:00pm
Cost: 5$ / All of the ticket sales proceeds will be given to Prosper Canada, a national charity dedicated to expanding economic opportunity for Canadians living in poverty through program and policy innovation.
NEW! To celebrate the arrival of summer and our last event before the summer break, the poutine bar will be replaced by a premium Mac N ‘Cheese bar including beer béchamel, a creamy blend of Swiss, cheddar & American cheeses, house-smoked bacon, grilled sausages, smoked chicken, sliced scallions and roasted mushrooms. It’s a special occasion you don’t want to miss!
The first 75 participants to register and to show up at the event before 5:30pm will receive a 10$ coupon for a free drink of their choice. No coupons will be given after 5:30pm.
To reserve your spot: Eventbrite – Espace MicroCaps 5to7 Cocktail – Summer 2018
The presenting companies have been hand-picked based on the attractiveness of their business model, market opportunity and fundamentals.
FLYHT Aerospace Solutions (TSX-V : FLY)
About: FLYHT’s mission is to improve aviation safety, efficiency and profitability. Airlines, leasing companies, fractional owners and original equipment manufacturers have installed the Automated Flight Information Reporting System (AFIRS) on their aircrafts to capture, process and stream aircraft data with real-time alerts. AFIRS sends this information through satellite networks to the UpTime cloud-based data center, which provides aircraft operators with direct insight into the operational status and health of their aircraft and enables them to take corrective action to maintain the highest standard of operational control.
Opportunity: Not only do FLYHT’s technologies improve the safety of aircrafts and help save lives, they also reduce operational and maintenance costs for aircraft operators, thus providing an attractive ROI. The company holds many patents and regulatory certifications, creating solid barriers to entry around its business. In its most recent quarter (Q1 2018), the company generated $3.3M in revenue, 50% of which was derived from long-term recurring revenue contracts (typically signed for 5 years) and OEM licensing fees. With an already impressive backlog of $26M and large countries such as China moving forward with new regulations for aircraft safety, it seems like FLYHT is perfectly positioned to benefit from strong industry tailwinds in the months and years to come!
Ortho Regenerative Technologies (CSE : ORTH)
About: Ortho RTi is an emerging Orthopaedic and Sports Medicine technology company dedicated to the development of novel therapeutic tissue repair devices to dramatically improve the success rate of sports medicine surgeries. The company’s proprietary biopolymer has been specifically designed to increase the healing rates of sports related injuries to ligaments, tendons and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention.
Opportunity: Ortho RTi is based in Montreal and its technology, developed at Ecole Polytechnique, has received $12M in research funding to date. Ortho’s main development program is Ortho-R, indicated for the treatment of rotator cuff tears. According to the company, this represents the fastest path to approval for commercial sales in the US sports medicine market. On May 31st, 2018, the company raised $1.44M through a private placement, which provides an important part of the necessary funding to move towards the initiation of human clinical trials in 2019. Success in clinical trials and getting a human ‘’proof of concept’’ for the technology will be significant value-creation milestones over the coming quarters. We should also mention that the company’s largest shareholder, Steve Saviuk (~26% ownership), is a smart venture capital investor and pharmaceutical entrepreneur. Those who are familiar with our investing style know that we love to invest alongside smart investors, so Ortho RTi is definitely a company we follow!
NuRAN Wireless (CSE : NUR)
About: Based in Quebec City, NuRAN Wireless is a leading supplier of mobile and broadband wireless infrastructure solutions. Its innovative radio access network (RAN), core network, and backhaul products dramatically drop the total cost of ownership, thereby creating new opportunities for established, as well as emerging mobile network operators. Indoor coverage, isolated rural communities, offshore platforms and ships, NuRAN Wireless helps its customers reach everyone, everywhere.
Opportunity: NuRAN’s team has more than 30 years of experience in engineering and has developed low-energy, low-cost wireless systems that are far more effective than anything currently on the market. An important validation of the technology is the fact that the company has been working with Facebook for the last 3 years as well as major network operators around the globe. NuRAN’s goal is to provide the equipment necessary to connect the next billion people in rural emerging markets. Over the last few years, NuRAN worked on getting its equipment certified with network operators and is now expecting to land multi-million, multi-year contracts over the coming quarters. Having closed the first tranche of a private placement on June 7th, 2018, for gross proceeds of $2.5M, NuRAN is now ready to advance its expansion globally!
This event will be the last one before the summer break. We are glad to conclude the first half of 2018 with these three amazing companies, and we hope you’ll enjoy! Again, to book a ticket, please click here.
We hope to see many of you on June 19th!
Philippe and Mathieu
Espace MicroCaps is under contract with Rivemont Investments (“Rivemont”) to provide securities and strategy analysis for the Rivemont MicroCap Fund (the “Fund”). In other words, Espace MicroCaps acts as external expert/consultant for the Fund. In return for this expertise, Espace MicroCaps is remunerated by Rivemont.
Decisions as to whether or not to trade a security for the Fund are made exclusively by Rivemont.
For full disclosure and transparency, regarding the companies that will present at our 5to7 Cocktail – Summer 2018 or that were mentioned in this article, the Fund:
- Holds no securities of FLYHT Aerospace Solutions (FLY.V), Ortho Regenerative Technologies (ORTH.C) and Nuran Wireless (NUR.C). Although the Fund does not hold any securities of these companies as of today, the Fund may acquire these securities in the future.
The main objective of the 5to7 Cocktail events that we hold on a regular basis is to allow very small companies to present their products and services and to tell their story to a new investing public.
Each company that will present at the event will pay Espace MicroCaps an amount of $2,000 + taxes. This amount is used to cover the cost of drinks and hors d’oeuvres offered during the meeting and to compensate Espace MicroCaps for the efforts related to the organization of the meeting.
Company presentations are neither an offer to sell nor a solicitation of an offer to purchase securities and should not be considered legal, tax, financial or investment advice.
Espace MicroCaps is not responsible for direct or indirect trading losses caused by the information presented by companies at the event. Everyone is advised to make their own analyzes and inquiries and to consult their own professional advisers with respect to legal, tax, accounting and other matters relating to the acquisition, holding or disposition of an investment.